RetinalGenix appoints Dr. Dessislava Boneva as director

RetinalGenix Technologies Inc.

Dr. Boneva appointed to board effective December 4, 2023.
She is a trauma surgeon with board certifications in surgery and surgical critical care.
No family relationships or material interests with company executives.
Serves as Surgery Clerkship Director/Clinical Assistant Professor at Nova Southeastern University.
Fellow of American College of Surgeons with 20+ years of experience.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Dessislava Boneva

director

RTGN · RetinalGenix Technologies Inc.

Effective: 2023-12-04
Filed: December 6, 2023, 6:59 PM ET

On December 4, 2023, the Board of Directors (the “Board”) of RetinalGenix Technologies Inc. (the ‘Company”) appointed Ms. Dessislava (Dessy) Boneva M.D. FACS, to serve as a director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Dessislava Boneva was appointed as director at RetinalGenix Technologies Inc..

Action: appointed
Role: director

Exact text from the filing

On December 4, 2023, the Board of Directors (the “Board”) of RetinalGenix Technologies Inc. (the ‘Company”) appointed Ms. Dessislava (Dessy) Boneva M.D. FACS, to serve as a director of the Company.

View on SEC.gov

RetinalGenix Technologies Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-043870

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.